Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of oral penicillins on gut microbiota in healthy volunteers
2019-000953-30Phase 2Active
- Sponsor
- Akademiska sjukhuset
- Start
- Mar 2019
- Modality
- Small Molecules, Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of phenoxymethylpenicillin, amoxicillin and amoxicillin + clavulanate in bacterial disease (4 arms), sponsored by Akademiska sjukhuset. Primary endpoints: Intestinal microbiota diversity and composition, Prevalence of multidrug-resistant Gram-negative bacteria and 1 more. Started Mar 2019; status: active.
02
Drugs
phenoxymethylpenicillinamoxicillinamoxicillin + clavulanate
03
Conditions
bacterial disease
Beyond the preview
Go deeper on 2019-000953-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-000953-30.